dc.contributor.author |
Brînza, Gabriela |
|
dc.date.accessioned |
2020-11-09T13:26:23Z |
|
dc.date.available |
2020-11-09T13:26:23Z |
|
dc.date.issued |
2020-10 |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/12732 |
|
dc.identifier.uri |
https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii |
|
dc.description |
State University of Medicine and Pharmacy "Nicolae Testemiteanu" Chișinău, Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare |
en_US |
dc.description.abstract |
Introduction:
• Estrogens have efects not only on
gonads but also on the hippocampus
and the prefrontal cortex area.
• The fluctuations of estrogen levels
directly influence cognitive functions,
an important point in menopause
management. Purpose:
To study the importance of estrogens in
neuroprotection and the effectiveness of
hormonal therapy depending on the age,
type (natural/ induced) and stage
(early/ late) of the menopause. Material and methods:
This is the synthesis of 20 medical research
articles published in the period of 2014-2019,
found with the research motors PubMed,
NCBI and Sciencedirect.
Results:
• Clinical studies have proved that estrogens mediated
effects are a result of interaction with the receptors ERα,
ERβ and GPER1 from the neurons of the hippocampus
and prefrontal cortex.
• Estrogens mediate:
the dendritic density growth thus
helping the formation of new synapses,
stimulating the glycolytic over
ketogenic metabolism,
maintaining Ca⁺ homeostasis.
These effects are important for the optimal functioning
of the memory and for the reduction of neurodegenerative
processes.
• The lower levels of circulating estrogens during
menopause can cause:
memory alterations,
neural hypometabolism,
risk of developing dementia.
Conclusions:
Hormone replacement therapy for the promotion of
neuroprotection shows eficacy depending on the time
of administration and reported to the natural or surgical
menopause onset. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" |
|
dc.subject |
estrogen |
en_US |
dc.subject |
menopause |
en_US |
dc.subject |
hormone therapy |
en_US |
dc.subject |
dementia |
en_US |
dc.title |
The effects of estrogens on brain plasticity |
en_US |
dc.type |
Other |
en_US |